Exploring the genetics behind heart and muscle diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on understanding the genetic factors associated with cardiovascular and neuromuscular diseases, specifically cardiomyopathy, arrhythmias, and muscular dystrophy. Researchers will collect blood samples to screen for mutations in genes linked to these disorders. The study aims to identify genetic regions that contribute to the development of these conditions, particularly in families with multiple affected members. By examining these genetic factors, the research seeks to enhance our understanding of the hereditary nature of these diseases.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients of all ages will be considered for the study. In particular, families with more than one affected relative will be sought.

Exclusion Criteria:

* Subjects without a suspected inherited cardiovascular or neuromuscular disorder will be excluded from this study.

Where it's running

• University of Chicago
  Chicago, Illinois, United States Recruiting

Study contacts

• Principal investigator: Elizabeth McNally, MD PhD — University of Chicago
• Study coordinator: Lisa Dellefave, MS
• Email: Ldellefa@medicine.bsd.uchicago.edu
• Phone: 773-702-4310

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding the genetics of arrhythmia-induced cardiomyopathy

  This study is trying to see if certain genetic traits in people with arrhythmia-induced cardiomyopathy can help predict their heart health and outcomes after treatment.

  Recruiting at 2 sites Hospital Universitario 12 de Octubre · Ciudad Real, Castille-La Mancha and 3 other locations · NCT06896266

• Case-Based Collaborative Learning to Improve Arrhythmia Recognition for New ICU Nurses

  A randomized study tests whether case-based collaborative learning helps new ICU nurses recognize arrhythmias and feel safer about patient care.

  Recruiting Çanakkale Onsekiz Mart University · Istanbul, Kartal · NCT07780448

• VM100: a nutritional supplement to see if it improves quality of life for boys with Duchenne

  This Phase 2 study tests VM100, a nutritional drink, in boys aged 8 and up with Duchenne muscular dystrophy to see if it can improve quality of life and reduce fatigue.

  Recruiting Phase 2 University of Florida · Gainesville, Florida · NCT07766980

• ATR 1072 in PRKAG2 Syndrome

  A first-in-human study tests ATR 1072 to see if it is safe and how it behaves in adults with PRKAG2 Syndrome.

  Recruiting Phase 1/2 Atrium Therapeutics · Kansas City, Missouri · NCT07738107

• Modeling heart failure in Duchenne and Becker muscular dystrophy to find surrogate heart measures

  This study will look at heart disease in people with Duchenne/Becker muscular dystrophy and carriers to see if MRI-based heart measures can predict death or major heart problems.

  Recruiting at 9 sites Vanderbilt University Medical Center · Sacramento, California and 8 other locations · NCT07674758

• AI-powered ECG tools to detect deadly heart rhythms and ICI-related myocarditis

  Researchers are testing AI-powered analysis of ECG data to see if it can help flag dangerous arrhythmias and myocarditis in people who may be affected by immune checkpoint inhibitors.

  Recruiting Groupe Hospitalier Pitie-Salpetriere · Paris · NCT07644715

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.